Author:
Kalisperakis Emmanouil,Karantinos Thomas,Lazaridi Marina,Garyfalli Vasiliki,Filntisis Panagiotis P.,Zlatintsi Athanasia,Efthymiou Niki,Mantas Asimakis,Mantonakis Leonidas,Mougiakos Theodoros,Maglogiannis Ilias,Tsanakas Panayotis,Maragos Petros,Smyrnis Nikolaos
Abstract
IntroductionMonitoring biometric data using smartwatches (digital phenotypes) provides a novel approach for quantifying behavior in patients with psychiatric disorders. We tested whether such digital phenotypes predict changes in psychopathology of patients with psychotic disorders.MethodsWe continuously monitored digital phenotypes from 35 patients (20 with schizophrenia and 15 with bipolar spectrum disorders) using a commercial smartwatch for a period of up to 14 months. These included 5-min measures of total motor activity from an accelerometer (TMA), average Heart Rate (HRA) and heart rate variability (HRV) from a plethysmography-based sensor, walking activity (WA) measured as number of total steps per day and sleep/wake ratio (SWR). A self-reporting questionnaire (IPAQ) assessed weekly physical activity. After pooling phenotype data, their monthly mean and variance was correlated within each patient with psychopathology scores (PANSS) assessed monthly.ResultsOur results indicate that increased HRA during wakefulness and sleep correlated with increases in positive psychopathology. Besides, decreased HRV and increase in its monthly variance correlated with increases in negative psychopathology. Self-reported physical activity did not correlate with changes in psychopathology. These effects were independent from demographic and clinical variables as well as changes in antipsychotic medication dose.DiscussionOur findings suggest that distinct digital phenotypes derived passively from a smartwatch can predict variations in positive and negative dimensions of psychopathology of patients with psychotic disorders, over time, providing ground evidence for their potential clinical use.
Subject
Psychiatry and Mental health
Reference34 articles.
1. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017.;James;Lancet.,2018
2. Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review.;Olivares;Ann Gene Psychiatry.,2013
3. Bipolar disorder.;Grande;Lancet.,2016
4. Does relapse contribute to treatment resistance? Antipsychotic response in first-vs. second-episode schizophrenia.;Takeuchi;Neuropsychopharmacology.,2019
5. Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia.;Subotnik;Am J Psychiatry.,2011
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. From Digital Phenotype Identification To Detection Of Psychotic Relapses;2023 IEEE 11th International Conference on Healthcare Informatics (ICHI);2023-06-26